Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The L-type voltage-gated calcium channel β1-subunit is a cytosolic, non-pore-forming auxiliary protein encoded by the CACNB1 gene. It physically associates with the α1 pore subunit of L-type calcium channels and is vital for proper cell surface expression, assembly, and modulation of channel gating kinetics. Through protein–protein interactions, it regulates calcium influx critical for excitation-contraction coupling in muscle and for cellular signal transduction in excitable tissues. Functional disruption, knockouts, or disease-linked mutations in β1 can lead to severe cardiac or muscular pathophysiology. The β1-subunit is essential for L-type calcium channel function but is not a drug target itself; it is critical for disease biology and underlies many functional and therapeutic properties of the entire channel complex.
For drugs targeting the L-type channel, mechanism includes: Inhibition (blockade) of calcium influx through the α1 subunit β1-subunit increases functional expression and alters gating kinetics, potentially affecting sensitivity to inhibitors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on L-type voltage-gated calcium channel β1-subunit (Cavβ1).